Rinvoq LQ 1 MG/ML solution 180ML
Ended Awarded
- Contract number
- SPE2DB25FJJ03
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,402
Award facts
- Contract value 100% obligated
- $10,402.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,402.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of RINVOQ LQ 1 mg/ml solution in 180ml quantities. This non-set-aside competitive award is scheduled for ultimate completion by September 2, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a Janus kinase inhibitor used in the treatment of rheumatoid arthritis and other inflammatory conditions, representing a specialty pharmaceutical product critical to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a prime vendor for federal medical procurement across multiple therapeutic domains. The company's participation in DLA's Pharmaceutical Prime Vendor Global Program reflects its significant role in supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with comprehensive pharmaceutical and medical supply solutions worldwide.
Quick answers
Who was awarded contract SPE2DB25FJJ03?
SPE2DB25FJJ03 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FJJ03 worth?
The government has obligated $10,402 on SPE2DB25FJJ03.
Is contract SPE2DB25FJJ03 an order under another contract?
Yes. SPE2DB25FJJ03 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJJ03 competed?
The extent of competition for SPE2DB25FJJ03 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award